Skip to content

Study · Measured the body's own peptide · 2019

1 result

A novel technique to diagnose non-melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors.

Fujimura T, Okabe T, Tanita K, Sato Y, Lyu C, Kambayashi Y, Maruyama S, Aiba S

Experimental dermatology12 Aug 2019Cited by 12 (Europe PMC)

PMID31264287 (opens in a new tab)DOI10.1111/exd.13997 (opens in a new tab)PepBankPUB-31264287
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In extramammary Paget's disease and squamous cell carcinoma, the percentage of cells producing the body's own LL37 was significantly higher in invasive than in non-invasive lesions.

    In plain wordsIn skin cancers, invasive tumours had more cells making the body's own LL37 than non-invasive ones.

    Peptide
    LL-37
    Outcome
    IncreasePercentage of LL37-producing cells in invasive versus non-invasive EMPD and SCC
    Study

    n: not reported in source

    Comparator
    Non-invasive EMPD and SCC
    Outcome group
    Cancer cell invasion and metastasis · Cancer

    Source sentences

    Summary
    Immunohistochemical staining showed that the percentage of LL37-producing cells was significantly increased in invasive EMPD and SCC compared to that in non-invasive EMPD and SCC.
    1 context sentence
    Summary · context
    In addition, to investigate the stromal factors that might affect ETC, immunohistochemical staining for LL37, periostin (POSTN), MMP12, and MMP28 was performed.

    This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:57 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.